A registration statement on Form F-10 relating to the Offering (including such prospectus) has also been filed with the U.S. The preliminary short form prospectus for the Offering has been filed, and an amendment to the preliminary short form prospectus containing the definitive terms of the Offering will be filed, with the securities commissions or similar securities regulatory authorities in each of the provinces of Canada except Québec.
In addition, if the Company is not able to complete a potential loan transaction contemplated by a non-binding term sheet prior to February 15, 2023, the Company expects to use a portion of the proceeds from the Offering to fund amounts required to be paid to complete the Company's previously announced pending acquisition of the Alta Mesa ISR uranium project (the "Alta Mesa Acquisition").Ĭlosing of the Offering, which is expected on or about Febru(the "Closing Date"), is subject to market and other customary conditions, including approvals of the TSX Venture Exchange and the NYSE American. The Company expects to use the net proceeds from the Offering to maintain and advance the Company's material properties, acquire properties, plant upgrades, drilling, maintenance and refurbishment, community outreach and communications, licensing and permitting and for general corporate and working capital purposes in the manner as set forth in the preliminary short form prospectus. In addition, the Company has granted the Underwriters an option to purchase up to an additional 1,384,650 Units on the same terms and conditions exercisable at any time, in whole or in part, until 30 days following the Closing Date, for market stabilization purposes and to cover over-allotments, if any. Each Warrant will entitle the holder thereof to purchase one common share of the Company (a "Warrant Share") for a period of 36 months following the Closing Date (as defined herein) of the Offering at an exercise price of C$4.05 per Warrant Share, subject to adjustment in certain events. (" enCore" or the " Company") (NYSE American: EU) (TSXV: EU) in connection with its previously announced overnight marketed offering (the "Offering") today announced that it has entered into an underwriting agreement with Canaccord Genuity as lead underwriter, together with a syndicate of underwriters (the "Underwriters") for the sale of 9,231,000 units of the Company (the "Units") at a price of C$3.25 per Unit for total gross proceeds to the Company of approximately C$30 million.Įach Unit will consist of one common share in the capital of the Company (each a "Unit Share") and one-half of one common share purchase warrant (a "Warrant").
0 kommentar(er)
